Search

Your search keyword '"De Caterina, R"' showing total 684 results

Search Constraints

Start Over You searched for: Author "De Caterina, R" Remove constraint Author: "De Caterina, R" Search Limiters Full Text Remove constraint Search Limiters: Full Text
684 results on '"De Caterina, R"'

Search Results

3. Detecting the vulnerable carotid plaque: The Carotid Artery Multimodality imaging Prognostic study design

4. Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice:: GLORIA-AF Registry

9. Revascularization strategies versus optimal medical therapy in chronic coronary syndrome: a systematic review and network meta-analysis

12. Comparison of the efficacy and safety between different oral P2Y12 receptor inhibitors in patients with acute coronary syndrome: a systematic review and meta-analysis

15. Neuroimaging evaluation of unilateral asymptomatic carotid plaque ulceration: preliminary results of the Carotid Artery Multimodality imaging Prognostic study

18. Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study

19. Grey zones on dual antiplatelet therapy. Expert opinion

20. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era

21. Clinical experience with apixaban in atrial fibrillation: implications of AVERROES

25. Edoxaban treatment in real-world practice is highly concordant with ESC atrial fibrillation guidelines: results from the non-interventional global ETNA-AF program

32. Temporal trend of clinical events in patients with atrial fibrillation on edoxaban therapy: results from the non-interventional global ETNA-AF program

33. Design and rationale of the Edoxaban Treatment in routiNe clinical prActice for patients with Atrial Fibrillation in Europe (ETNA-AF-Europe) study

35. Elevated triglycerides and low HDL cholesterol predict coronary heart disease risk in patients with stable angina

37. Low bleeding and stroke rates with minor age-dependent increase confirm the safety and effectiveness of edoxaban in patients with atrial fibrillation across age groups: Two-year results from ETNA-AF

38. Annualized clinical event rates during two-year follow-up are low in 27,617 atrial fibrillation patients on edoxaban: results from the global noninterventional ETNA-AF program

41. Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering

42. Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study

43. Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: the Multicenter Italian CORIST Study

44. Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry

45. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Catalog

Books, media, physical & digital resources